Workflow Orchestration for Small Molecule Drug Clinical Trial Pre-screening

Small molecule drug clinical trial data originates from clinical trial organizations, Contract Research Organizations (CROs), and internal

Data Characteristics

Small molecule drug clinical trial data originates from clinical trial organizations, Contract Research Organizations (CROs), and internal pharmaceutical company databases. Data update frequencies vary. Public databases might update quarterly or annually, while internal trial data accumulates in real time as trials progress. Document structures typically include both structured and unstructured data. Structured data, such as subject demographics, biochemical indicators, adverse event codes (MedDRA), drug dosages, and key trial protocol parameters, often exists in CSV, Excel, or database records. Unstructured data includes physician handwritten notes from Case Report Forms (CRFs), imaging reports, and pathology analysis reports, primarily in PDF or Word formats. Fields and units require high standardization, for example, dosage units (mg), concentration (μg/mL), time points (days, weeks), and specific biomarker values.

Constraints Imposed by Data Characteristics on Workflow Orchestration

The diversity and standardization requirements of small molecule drug data impose specific constraints on workflow orchestration. Data source dispersion necessitates multi-source data integration modules to pull data from various databases and file systems. The strict normativity of structured data requires rigorous data cleaning, type validation, and unit conversion during the data preprocessing stage to ensure accuracy in subsequent analysis. The presence of unstructured data, particularly physician handwritten notes and pathology reports, requires the introduction of Optical Character Recognition (OCR) and Natural Language Processing (NLP) modules for information extraction and structuring, such as identifying adverse event descriptions and disease diagnoses. Furthermore, inconsistent data update frequencies demand that the workflow supports scheduled triggers and incremental updates to avoid reprocessing historical data and ensure pre-screening results are based on the latest information. Processing specific biomarker or genotype data might require external tool API calls for deeper bioinformatics analysis.

Configuration Guidelines

Configuration ItemRecommended ValueRationale
maxContext4000 charactersAccommodates common paragraph lengths in clinical trial reports while balancing recall efficiency.
Recall count (Recall Count)Top 10Reduces unnecessary computational overhead and focuses on core information while ensuring relevance.
Similarity threshold (Similarity Threshold)0.75Balances recall breadth and precision, avoids excessive noise, and ensures matching reliability.
PARSE_FILE_TIMEOUT_SECONDS600 secondsProcessing large PDFs or transcribing imaging reports can be time-consuming; this prevents timeouts.
http_request_timeout300 secondsExternal bioinformatics API response times are uncertain; this provides sufficient waiting time.
Chunk size (Segment Length)800–1200 charactersBalances semantic completeness with model processing capability, preventing information loss after long text segmentation.

Common Pitfalls

  • HTTP 504 Gateway Timeout errors occur when calling external APIs because the external API response time exceeds the http_request_timeout limit set in the workflow.
  • Knowledge base query results contain a large amount of irrelevant information, leading to decreased pre-screening accuracy. This is due to a Similarity threshold (Similarity Threshold) set too low, which fails to effectively filter out low-relevance document segments.
  • The workflow executes successfully, but certain key fields (e.g., adverse event type, dosage unit) are empty. This happens when unstructured data processing modules (OCR or NLP) are not configured correctly, preventing accurate extraction or standardization of this information.

Verification Steps

  • Simulate submitting case reports containing both structured and unstructured data. Check if the workflow correctly extracts and structures all key fields. Compare with expected results to confirm the accuracy of field values and units.
  • Execute a series of test cases with clear pre-screening outcomes. Observe if the workflow's pre-screening conclusions align with expectations. Check log outputs to confirm all branching logic executes as designed.
  • Verify the data update mechanism. Modify some source data and re-trigger the workflow. Confirm that the incremental update module identifies and processes the latest data, and that old data is not reprocessed.

Values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.